Ledger.Open graph →

SEC Form D · filed August 10, 2021

Hapten Sciences, Inc

Offering

$3.0M

Sold

—

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

MEMPHIS, TN

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Gary Prosterman · Memphis, TNExec · Director Gary L. Stevenson · Memphis, TNDirector Raymond J. Hage · Memphis, TNExec · Director Stephen L. Bandak · Memphis, TNDirector Daniel Hicklin · Cambridge, MAExec · Director Mark Azzopardi · Triq il-Qatta Swieqi, O1Director David Cordo · Cambridge, MADirector Arnold Oronsky · Cambridge, MAExec · Director Luke Evnin · Cambridge, MADirector Sakae Asanuma · Cambridge, MAExec · Director Wesley Capital Management, LLC · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗